• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VYGON UMBILICAL CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VYGON UMBILICAL CATHETER Back to Search Results
Model Number 270.05
Device Problem Fluid/Blood Leak (1250)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 01/04/2019
Event Type  Injury  
Manufacturer Narrative
The failed sample will be returned to vygon for device evaluation as part of the complaint investigation.The results of this investigation are still pending,and will be communicated to fda within 30 days of its conclusion.As batch is unknown, no review can be done.All umbilical catheters are 100% tested for tightness and non-obstruction during the manufacturing process.
 
Event Description
After 62 hours, a leakage of parenteral infusion was noticed on the external part of the umbilical catheter.It has been withdrawn.A part of 4,5 cm remained in the vein and necessitated a surgical intervention with dissection of umbilical vein.It was replaced by a peripheral venous line.No patient injury and no patient outcome up today but the physician could not exclude a cavernoma later.Only, a control by ultrasound in a few months would confirm that there is no patient outcome.
 
Event Description
After 62 hours,a leakage of parenteral infusion was noticed on the external part of the umbilical catheter.It has been withdrawn.A part of 4,5 cm remained in the vein and necessitated a surgical intervention with dissection of umbilical vein.It was replaced by a peripheral venous line.No patient injury and no patient outcome up today but the physician could not exclude a cavernoma later.Only, a control by ultrasound in a few months would confirm that there is no patient outcome.
 
Manufacturer Narrative
We received the involved umbilical catheter for evaluation.We noticed that the distal part of the tube has been pulled off.The catheter has been over stretched by the user.In the ifu the cautions are written as follows : -do not over stretch the catheter as it may rupture, causing embolism, -removal : the catheter is removed by gentle sustained traction close to the exist site( 2-3 cm).Do not over stretch the catheter.This event is not linked to a defect of the umbilical catheter.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UMBILICAL CATHETER
Type of Device
UMBILICAL CATHETER
Manufacturer (Section D)
VYGON
5 rue adeline
ecouen, 95440
FR  95440
MDR Report Key8274830
MDR Text Key134016718
Report Number2245270-2019-00004
Device Sequence Number1
Product Code FOS
Combination Product (y/n)N
PMA/PMN Number
K921352
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 02/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/24/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model Number270.05
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Yes
Date Manufacturer Received01/16/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age3 DA
-
-